Author: Mintel Group Ltd.
Last saved by: HTTP server

Gastrointestinal Remedies - UK - November 2013

INTRODUCTION
Definition
Methodology
Consumer research
Abbreviations
EXECUTIVE SUMMARY
The market
Figure 1: Best- and worst-case scenario for UK retail value sales of gastrointestinal remedies, 2008-18
Level of new product development falling
Figure 2: New product launches, by branded vs. own-label, 2009-13
Companies, brands and innovation
Figure 3: UK retail value sales of gastrointestinal remedies, by brand, year ending August 2013
The consumer
Figure 4: Gastrointestinal ailments suffered in last 12 months and treatments, September 2013
Figure 5: Selected attitudes towards treatment of gastrointestinal ailments, September 2013
Figure 6: Selected attitudes towards buying gastrointestinal remedies, September 2013
What we think
ISSUES IN THE MARKET
What role does own-label have in this category?
Why are people reluctant to take gastrointestinal remedies?
What are the opportunities for new innovations?
How will growth of the over-65s impact the category?
TREND APPLICATIONS
Trend: Transumers
Trend: Extend My Brand
Mintel Futures: East Meets West
 MARKET DRIVERS
Key points
Young urban professionals are a target group
Figure 7: Trends in the age structure of the UK population, 2008-18
The over-65s set to remain fastest-growing age group
Socio-economic groups – opportunities for industry growth
Figure 8: Forecast adult population trends, by socio-economic group, 2008-18
Consumers prioritise exercise over healthy eating
Figure 9: Factors important for a healthy lifestyle, November 2012
Gastrointestinal remedies and the NHS
Figure 10: Number of gastrointestinal prescription items dispensed, 2009-12
Gradual increase in foreign travel increases market options
Figure 11: UK residents’ visits abroad, by month, 2011-13
WHO’S INNOVATING?
Key points
Own-label launches show decline
Figure 12: New product launches, by branded vs. own-label, 2009-13
Figure 13: Examples of own-label launches, January-September 2013
Alternative formats increase in 2013
Figure 14: New product activity in gastrointestinal remedies, by format, 2009-13
Figure 15: Examples of alternative format launches, January-September 2013
Rise in time/speed claims
Figure 16: New product activity in gastrointestinal remedies, % share by leading claims, 2009-13
Figure 17: Examples of products with time/speed claims, January-September 2013
Majority of product launches flavourless
Figure 18: New product activity in gastrointestinal remedies, % share by leading flavours, 2009-13
MARKET SIZE AND FORECAST
Key points
Historical decline in value
Figure 19: UK retail value sales of gastrointestinal remedies, at current and constant prices, 2008-18
Rise in value predicted for the future
Figure 20: Best- and worst-case scenario for UK retail value sales of gastrointestinal remedies, 2008-18
Forecast methodology
SEGMENT PERFORMANCE
Key points
Rise in price per unit drives growth of diarrhoea treatments
Figure 21: UK retail value sales of gastrointestinal remedies, by segment, 2012 and 2013
MARKET SHARE
Key points
2013 is the year of the brands
Figure 22: UK retail value sales of gastrointestinal remedies, by brand, years ending August 2012 and August 2013
Gaviscon Double Action grows in value
Figure 23: UK retail value sales of indigestion remedies, by brand, years ending August 2012 and August 2013
Imodium remains the leader in anti-diarrhoeals
Figure 24: UK retail value sales of anti-diarrhoeals, by brand, years ending August 2012 and August 2013
Laxatives
Figure 25: UK retail value sales of laxatives, by brand, years ending August 2012 and August 2013
COMPANIES AND PRODUCTS
Bayer Healthcare
Figure 26: Financial performance of Bayer Healthcare UK & Ireland, 2011 and 2012
Figure 27: New product launches by Bayer, December 2012-August 2013
Reckitt Benckiser Group plc
Figure 28: Financial performance of Reckitt Benckiser, 2011 and 2012
Figure 29: New product launches by Reckitt Benckiser, December 2012-August 2013
Boehringer Ingelheim
Figure 30: Financial performance of Boehringer Ingelheim Ltd., 2011 and 2012
Figure 31: New product launches by Boehringer Ingelheim, December 2012-August 2013
GlaxoSmithKline
Figure 32: Financial performance of GlaxoSmithKline, 2011 and 2012
Figure 33: New product launches by GlaxoSmithKline, December 2012-August 2013
Alliance Boots
Figure 34: Financial performance of Alliance Boots, 2012 and 2013
Figure 35: New product launches by Alliance Boots, December 2012-August 2013
BRAND COMMUNICATION AND PROMOTION
Key points
Advertising spend peaked in 2011
Figure 36: Main media advertising expenditure of gastrointestinal remedies, 2009-13
Reckitt Benckiser continues to dominate advertising expenditure
Figure 37: Main media advertising expenditure on gastrointestinal remedies, by the top advertisers, January-August 2013
TV holds the majority of advertising spend
Figure 38: Main media advertising expenditure on gastrointestinal remedies, by media type, 2011 and 2012
CHANNELS TO MARKET
Key points
Supermarkets offer convenient purchasing
Figure 39: Estimated UK retail value sales of gastrointestinal remedies, by channel, 2012 and 2013
Chemists and pharmacies appeal with in-store experts
THE CONSUMER – EXPERIENCE AND MANAGEMENT OF GASTROINTESTINAL COMPLAINTS
Key points
Most people prefer to do nothing
Figure 40: Gastrointestinal ailments suffered in last 12 months and treatments, September 2013
Men are more likely to suffer from digestive health issues…
Figure 41: Gender differences in treatment of any gastrointestinal ailment, September 2013
…but women are more willing to take non-prescription remedies
Younger people more likely to let symptoms run their course
Lack of preparation when it comes to digestive health issues
Figure 42: Selected attitudes towards treatment of gastrointestinal ailments, September 2013
Men can be encouraged to take a more active approach to their digestive health
THE CONSUMER – PURCHASING OF GASTROINTESTINAL REMEDIES
Key points
Brand loyalty is high
Figure 43: Attitudes towards buying gastrointestinal remedies, September 2013
The holiday market
Few people go to the pharmacist for advice
THE CONSUMER – INTEREST IN NEW PRODUCT INNOVATION
Key points
Preventative measures are of interest
Figure 44: Interest in new product development, September 2013
Products with benefits beyond digestive health
THE CONSUMER – ATTITUDES TOWARDS GASTROINTESTINAL REMEDIES/ISSUES
Key points
People are sceptical of gastrointestinal remedies
Figure 45: Attitudes towards gastrointestinal remedies/issues, September 2013
Young people are confused
Gastrointestinal issues stir up emotions
CONSUMER TYPOLOGIES
Key points
Figure 46: Target groups for gastrointestinal remedies, September 2013
Remedy Ready – 40%
Who are they?
Diet Managers – 36%
Who are they?
Sceptics – 24%
Who are they?
APPENDIX – SEGMENT PERFORMANCE
Figure 47: UK retail volume sales of gastrointestinal remedies, by segment, 2012 and 2013
APPENDIX – THE CONSUMER – EXPERIENCE AND MANAGEMENT OF GASTROINTESTINAL COMPLAINTS
Figure 48: Gastrointestinal ailments suffered in last 12 months and treatments, September 2013
Figure 49: Gastrointestinal ailments suffered in last 12 months and treatments – All gastrointestinal ailments, by demographics, September 2013
Figure 50: Gastrointestinal ailments suffered in last 12 months and treatments – Heartburn, acid reflux or stomach ulcer, by demographics, September 2013
Figure 51: Gastrointestinal ailments suffered in last 12 months and treatments – Indigestion, by demographics, September 2013
Figure 52: Gastrointestinal ailments suffered in last 12 months and treatments – Diarrhoea, by demographics, September 2013
Figure 53: Gastrointestinal ailments suffered in last 12 months and treatments – Constipation, by demographics, September 2013
Figure 54: Gastrointestinal ailments suffered in last 12 months and treatments – Wind, bloating or flatulence, by demographics, September 2013
Figure 55: Gastrointestinal ailments suffered in last 12 months and treatments – Stomach cramps, by demographics, September 2013
Figure 56: Gastrointestinal ailments suffered in last 12 months and treatments – Motion sickness or nausea, by demographics, September 2013
Figure 57: Gastrointestinal ailments suffered in last 12 months and treatments – Stress or nervous stomach, by demographics, September 2013
Figure 58: Gastrointestinal ailments suffered in last 12 months and treatments – Irritable Bowel Syndrome, by demographics, September 2013
Figure 59: Gastrointestinal ailments suffered in last 12 months and treatments – Stomach irritation from lactose intolerance, gluten intolerance or other food sensitivity, by demographics, September 2013
Figure 60: Attitudes towards treating gastrointestinal ailments, September 2013
Figure 61: Attitudes towards treating gastrointestinal ailments, by demographics, September 2013
Figure 62: Attitudes towards treating gastrointestinal ailments, by demographics, September 2013 (continued)
APPENDIX – THE CONSUMER – PURCHASING OF GASTROINTESTINAL REMEDIES
Figure 63: Attitudes towards buying gastrointestinal remedies, September 2013
Figure 64: Attitudes towards buying gastrointestinal remedies, by demographics, September 2013
Figure 65: Attitudes towards buying gastrointestinal remedies, by demographics, September 2013 (continued)
Figure 66: Attitudes towards buying gastrointestinal remedies, by demographics, September 2013 (continued)
APPENDIX – THE CONSUMER – INTEREST IN NEW PRODUCT INNOVATION
Figure 67: Interest in new product development, September 2013
Figure 68: Interest in new product development – Snacks or drinks that aid digestive issues, by demographics, September 2013
Figure 69: Interest in new product development – Remedies containing my daily dose of vitamins, by demographics, September 2013
Figure 70: Interest in new product development – After-treatments to help prevent experiencing a gastrointestinal issue again, by demographics, September 2013
Figure 71: Interest in new product development – Preventative remedies that I can take before experiencing a gastrointestinal issue, by demographics, September 2013
Figure 72: Interest in new product development – A remedy to be taken before a meal to prepare the stomach, by demographics, September 2013
Figure 73: Interest in new product development – Remedies/treatments that aid weight management as well as digestive issues, by demographics, September 2013
Figure 74: Interest in new product development – Detoxifying treatments for the digestive system, by demographics, September 2013
Figure 75: Interest in new product development – Apps to help identify foods that could be causing digestive issues, by demographics, September 2013
Figure 76: Interest in new product development – A powder remedy to sprinkle on top of food, by demographics, September 2013
Figure 77: Interest in new product development – Heat patches that can improve digestion, by demographics, September 2013
Figure 78: Interest in new product development – Colonic/abdominal massaging, by demographics, September 2013
Figure 79: Interest in new product development – Colon cleansing/colonic irrigation, by demographics, September 2013
Figure 80: Interest in new product development, by ailments and treatments – All gastrointestinal ailments, September 2013
APPENDIX – THE CONSUMER – ATTITUDES TOWARDS GASTROINTESTINAL REMEDIES/ISSUES
Figure 81: Attitudes towards gastrointestinal remedies/issues, September 2013
Figure 82: Agreement with the statement ‘It’s difficult to know what causes gastrointestinal issues’, by demographics, September 2013
Figure 83: Agreement with the statement ‘I get frustrated when gastrointestinal issues get in the way of things I want to do’, by demographics, September 2013
Figure 84: Agreement with the statement ‘It is possible to manage gastrointestinal issues with diet alone’, by demographics, September 2013
Figure 85: Agreement with the statement ‘It’s difficult to know which remedies are best suited for specific gastrointestinal issues’, by demographics, September 2013
Figure 86: Agreement with the statement ‘It’s easy to become reliant on non-prescription gastrointestinal remedies’, by demographics, September 2013
Figure 87: Agreement with the statement ‘It’s better to treat gastrointestinal issues with natural remedies’, by demographics, September 2013
Figure 88: Agreement with the statement ‘Suffering from gastrointestinal issues makes me feel unattractive’, by demographics, September 2013
Figure 89: Agreement with the statement ‘I am concerned about the side effects of non-prescription gastrointestinal remedies’, by demographics, September 2013
Figure 90: Agreement with the statement ‘I feel embarrassed talking about gastrointestinal issues’, by demographics, September 2013
Figure 91: Agreement with the statement ‘Suffering from gastrointestinal issues affects my social life’, by demographics, September 2013
Figure 92: Agreement with the statement ‘Non-prescription gastrointestinal remedies are used to manage a bad diet’, by demographics, September 2013
Figure 93: Attitudes towards gastrointestinal remedies/issues, by ailments and treatments – All gastrointestinal ailments, September 2013
APPENDIX – CONSUMER TYPOLOGIES
Figure 94: Target groups, September 2013
Figure 95: Ailments and treatments, by target groups, September 2013
Figure 96: Attitudes towards treating gastrointestinal ailments, by target groups, September 2013
Figure 97: Interest in new product innovation, by target groups, September 2013
Figure 98: Interest in new product development, by target groups, September 2013
Figure 99: Attitudes towards gastrointestinal remedies/issues, by target groups, September 2013

This report is supplied in accordance with Mintel's terms and conditions.  
© Mintel Group Ltd.